Farmax India Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
- Paid Up Capital ₹ 53.42 Cr
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 0.10 M
- Satisfied Charges ₹ 51.30 Cr
- Revenue Growth -73.50%
- Profit Growth 71.77%
- Ebitda 82.44%
- Net Worth -30.79%
- Total Assets -9.40%
About Farmax India
Farmax India Limited (FIL) is a Public Limited Indian Non-Government Company incorporated in India on 08 November 1995 and has a history of 29 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Farmax Retail (India) Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 60.00 Cr and a paid-up capital of Rs 53.42 Cr.
The company currently has active open charges totaling ₹0.10 M. The company has closed loans amounting to ₹51.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Farmax India Limited India is Vijay Gurramkonda as CFO. Srinivasareddy Reddy, Shrawan Gone, Vijay Gurramkonda, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L27109TG1995PLC022190
- Company No.
022190
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Nov 1995
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
What products or services does Farmax India Limited offer?
Farmax India Limited offers a wide range of products and services, including Apparel Fabrics & Clothing Textiles, Silk Textile, Milk, Buffalo Milk, Wheat Flour, Organic Wheat Flour, Coconut Oil, Organic Coconut Oil, Herbal Soaps, Sandalwood Soap.
Who are the key members and board of directors at Farmax India?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivasareddy Reddy ![]() | Managing Director | 20-Sep-2023 | Current |
Vijay Gurramkonda | CFO | 09-Jun-2024 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vijay Gurramkonda ![]() | Director | 14-Feb-2024 | Current |
Shrawan Gone ![]() | Director | 14-Feb-2024 | Current |
Lydia Pakala ![]() | Director | 14-Feb-2024 | Current |
Venkata Karingula ![]() | Director | 14-Feb-2024 | Current |
Financial Performance of Farmax India.
Farmax India Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 73.5% decrease. The company also saw a substantial improvement in profitability, with a 71.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.79%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Farmax India?
In 2017, Farmax India had a promoter holding of 37.89% and a public holding of 62.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0.01 Cr
₹51.30 Cr
Charges Breakdown by Lending Institutions
- Kotak Mahindra Bank Ltd. : 0.01 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
13 Oct 2003 | Kotak Mahindra Bank Ltd. | ₹0.10 M | Open |
07 Jun 2010 | State Bank Of India | ₹30.01 Cr | Satisfied |
04 Mar 2009 | Union Bank Of India | ₹1.25 Cr | Satisfied |
09 Mar 2007 | Union Bank Of India | ₹19.64 Cr | Satisfied |
09 Nov 2005 | Union Bank Of India | ₹4.00 M | Satisfied |
How Many Employees Work at Farmax India?
Unlock and access historical data on people associated with Farmax India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Farmax India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmax India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.